Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lyra Therapeutics (LYRA) Prepaid Assets (2021 - 2025)

Lyra Therapeutics (LYRA) has disclosed Prepaid Assets for 5 consecutive years, with $964000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Prepaid Assets fell 65.79% to $964000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $964000.0, a 65.79% decrease, with the full-year FY2024 number at $2.4 million, up 18.38% from a year prior.
  • Prepaid Assets was $964000.0 for Q3 2025 at Lyra Therapeutics, down from $1.3 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $2.9 million in Q4 2022 to a low of $964000.0 in Q3 2025.
  • A 5-year average of $2.0 million and a median of $2.1 million in 2023 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: soared 44.46% in 2022, then tumbled 65.79% in 2025.
  • Lyra Therapeutics' Prepaid Assets stood at $2.2 million in 2021, then skyrocketed by 35.19% to $2.9 million in 2022, then fell by 29.54% to $2.1 million in 2023, then increased by 18.38% to $2.4 million in 2024, then plummeted by 60.62% to $964000.0 in 2025.
  • Per Business Quant, the three most recent readings for LYRA's Prepaid Assets are $964000.0 (Q3 2025), $1.3 million (Q2 2025), and $2.2 million (Q1 2025).